Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009–2010

Analysis of Anthrax Immune Globulin Intravenous with Antimicrobial Treatment in Injection Drug Users, Scotland, 2009–2010

We studied anthrax immune globulin intravenous (AIG-IV) use from a 2009–2010 outbreak of Bacillus anthracis soft tissue infection in injection drug users in Scotland, UK, and we compared findings from 15 AIG-IV recipients with findings from 28 nonrecipients. Death rates did not differ significantly...

Full description

Bibliographic Details
Main Authors: Xizhong Cui, Leisha D. Nolen, Junfeng Sun, Malcolm Booth, Lindsay Donaldson, Conrad P. Quinn, Anne E. Boyer, Katherine A. Hendricks, Sean Shadomy, Pieter Bothma, Owen Judd, Paul McConnell, William A. Bower, Peter Q. Eichacker
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2017-01-01
Series:Emerging Infectious Diseases
Subjects:
Bacillus anthracis
anthrax
infection
treatment
anthrax immune globulin intravenous
AIG-IV
Online Access:https://wwwnc.cdc.gov/eid/article/23/1/16-0608_article

Similar Items

Similar Items